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background: Earlier studies have shown an inverse association between the presence of nausea and vomiting in pregnancy (NVP) and
spontaneous abortion (SAB), but no study to date has examined the effects of symptom duration on the risk of SAB.
methods: We examined NVP symptom severity and duration in relation to the occurrence of SAB. Data were collected from 2407
pregnant women in three US cities between 2000 and 2004 through interviews, ultrasound assessments and medical records abstractions.
Discrete-time continuation ratio logistic survival models were used to examine the association between NVP and pregnancy loss.
results: Lack of NVP symptoms was associated with increased risk for SAB [adjusted odds ratio (OR) ¼ 3.2, 95% confidence interval
(CI): (2.4, 4.3)], compared with having any symptoms. Reduced risks for SAB were found across most maternal age groups for those with
NVP for at least half of their pregnancy, but the effects were much stronger in the oldest maternal age group [OR ¼ 0.2, 95% CI: (0.1, 0.8)].
conclusions: The absence of NVP symptoms is associated with an increased risk of early pregnancy loss. As symptom duration
decreases, the likelihood of early loss increases, especially among women in the oldest maternal age group.
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Introduction
Nausea and vomiting in early pregnancy (NVP) affects 50–90% of
women (Klebanoff et al., 1985; Klebanoff and Mills, 1986; Tierson
et al., 1986; Lacroix et al., 2000; Chan et al., 2009) and is commonly
the earliest symptom of pregnancy. Severity of symptoms, timing of
symptom onset and duration vary both among women and across
multiple pregnancies of a woman. Symptoms can begin as early as
2–4 weeks’ gestation (Gadsby et al., 1993; Lacroix et al., 2000) and
commonly resolve by 20 weeks’ gestation (Gadsby et al., 1993; Brous-
sard and Richter, 1998), but may continue to affect up to 20% of
women beyond 20 weeks’ gestation (Broussard and Richter, 1998).
The pathogenesis of NVP is poorly understood, but has been attrib-
uted to rises in the serum levels of human chorionic gonadotrophin
(hCG) and estrogen (Jarnfelt-Samsioe et al., 1983; Cunningham
et al., 2005). A number of maternal characteristics, including primipar-
ity (Bashiri et al., 1995), younger maternal age (Klebanoff et al., 1985;
Bashiri et al., 1995) and lower education (Klebanoff et al., 1985) have
been associated with NVP, and higher maternal BMI has been ident-
ified as a risk factor for vomiting (Klebanoff et al., 1985).
Spontaneous abortion (SAB) is defined as a pregnancy loss before
20 completed weeks’ gestation. While 10–14% of all clinically
recognized pregnancies result in SAB (Wilcox et al., 1985; Wilcox,
2010), the actual rate of pregnancy loss, as shown with the use of bio-
chemical assays, is actually two to five times higher (Ellish et al., 1996;
Forbes, 1997; Wilcox et al., 1999). Current knowledge on causes of
early pregnancy loss is limited, but two consistent risk factors are
older maternal age and history of previous pregnancy loss (Andersen
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et al., 2000; de La Rochebrochard and Thonneau, 2002; George et al.,
2006). Many earlier studies that examined the association between
NVP and SAB (Jarnfelt-Samsioe et al., 1983; Klebanoff et al., 1985;
Tierson et al., 1986; Weigel and Weigel, 1989a,b; Weigel et al.,
2006) have methodological limitations. These include aspects of par-
ticipant selection criteria, sample size, ascertainment of NVP infor-
mation and classification of NVP symptoms and analytical approach.
These differences in study design and analysis make comparison and
interpretation of results difficult. Most importantly, no earlier study
has examined the association between symptom duration and SAB.
We recruited a large cohort of women early in gestation or before
they conceived so early clinically detectable pregnancy losses could be
identified. We were able to collect detailed prospective data on the
pregnancy, characteristics and timing of nausea symptoms and vomit-
ing episodes, behavioral factors and other maternal characteristics.
Using these data, we examined the association between severity
and duration of NVP and SAB.
Materials and Methods
Some of our methods have been described elsewhere (Promislow et al.,
2004; Savitz et al., 2005, 2006; Chan et al., 2009). We identified and
recruited women who were newly pregnant and women who were
trying to conceive from Raleigh, NC; Memphis, TN and Galveston, TX.
Women were recruited from prenatal clinics and community locations
(e.g. grocery stores, libraries, coffee shops, churches) between 2000 and
2004 for a prospective cohort epidemiological study (right from the
start) that examined the relationship between drinking water disinfection
by-products and early pregnancy loss. Women were eligible to be in the
study if they were at least 18 years old and pregnant at ,12 weeks ges-
tation or had been attempting pregnancy for fewer than 6 months. The
recruitment process has been described in detail elsewhere (Promislow
et al., 2004; Savitz et al., 2005, 2006). All women completed a screening
interview to determine eligibility.
An early pregnancy endovaginal ultrasound was sought around 9 weeks’
gestation (median gestational age at ultrasound ¼ 9.3 weeks) to confirm
pregnancy viability and to ascertain the gestational age of the fetus. We
found that self-reported last menstrual period (LMP) in this cohort was
highly reliable based on the comparison of self-reported LMP and ultra-
sound dating (Savitz et al., 2005, 2006); therefore, self-reported LMP
was primarily used to calculate gestational age. Ultrasound dates were
used (18%) only when they differed from self-reported dates by more
than 7 days or when LMP was not known.
Detailed interviews took place at baseline (shortly after enrollment but
at no later than 16 weeks’ gestation) and at follow-up (between 20 and 25
weeks’ gestation) to collect more detailed information on health beha-
viors, medical and reproductive history, and current pregnancy history
and symptoms such as NVP. All women provided this information regard-
less of their pregnancy outcome; women who experienced an SAB before
a scheduled interview were contacted for an interview as soon as possible,
and the language in the interview was amended to take into consideration
the pregnancy loss.
Timings of onset (start of NVP symptoms) and ending dates were col-
lected separately via self-report for symptoms of nausea and vomiting epi-
sodes, noting the month, day and year. For those who were unable to
recall the exact day of onset, we collected timing information with
respect to ‘week in the month’ and we imputed the day as the mid-point
of the week. We assigned symptom ending date at 20 weeks for women
whose symptoms had not subsided at the time of the interview (26%
nausea only; 13% both nausea and vomiting).
Absence or presence of NVP symptoms, whether nausea alone or with
the addition of vomiting episodes, was used to characterize symptom
severity into: (1) no symptoms, (2) nausea only and (3) nausea symptoms
with vomiting episodes. Because symptom start and ending dates and the
time period in which each individual was considered to be at risk for NVP
varied, duration was a time-varying covariate for each individual and was
categorized as: (1) no symptoms by week j, (2) having NVP for ,half of
pregnancy at gestational week j and (3) having NVP for ≥half of pregnancy
at gestational week j. Pregnancy outcome data were ascertained via par-
ticipant self-report, with confirmation through medical record abstraction
and/or with the presence or absence of corresponding vital records for
the pregnancy. We defined SAB as a loss of a pregnancy before 20 com-
pleted weeks’ gestation from LMP.
We used a discrete-time continuation ratio logistic survival model (Cole
and Ananth, 2001; Singer and Willett, 2003; Rodriguez, 2008) to examine
pregnancy loss in relation to symptoms of NVP. Adjusted odds ratios
(ORs) and 95% confidence intervals (CIs) were generated for the con-
ditional probability of having a pregnancy loss in a given gestational
week, conditional on a woman’s pregnancy having survived to the begin-
ning of that gestational week. Pregnancies were followed from the time
of enrollment into the study and contributed to the risk set until 20
weeks’ gestation, time of SAB or last point of study contact for those
loss-to-follow-up, whichever came first.
Two distinct discrete-time survival models were used to estimate the
sub-classes (one model for severity and another for duration) of symp-
toms of NVP in relation to early pregnancy loss. The covariates that we
considered were identified using a directed acyclic graph; these were
known to be predictors of pregnancy loss, including maternal age (Ander-
sen et al., 2000; de La Rochebrochard and Thonneau, 2002), race and eth-
nicity (Wen et al., 2001), maternal education, marital status, smoking
(Parazzini et al., 1997), alcohol use (Henderson et al., 2007), BMI
(Lashen et al., 2004; Metwally et al., 2008), age at menarche (Parazzini
et al., 1997), parity (Wen et al., 2001) and pregnancy loss history
(George et al., 2006). Effect measure modifiers were evaluated by com-
paring stratum-specific estimates of each covariate of interest along with
examination of the likelihood ratio test using a criterion of P , 0.15. Cov-
ariates that were deemed not to be modifiers were then examined next as
potential confounders. Covariates were retained as confounders in the
final models if they changed the effect estimates for the exposure of inter-
est by .10% when removed from the model. In each model, maternal
race and ethnicity, maternal education, marital status, alcohol use, age at
menarche, parity and pregnancy loss history were evaluated as potential
confounders; maternal age was included as an effect measure modifier.
All statistical analyses were conducted using SAS (SAS Institute Inc.,
Cary, NC, USA). This study was reviewed and approved by The
UNC-Chapel Hill Public Health Institutional Review Board (study
#06-0285).
Results
A total of 2766 women were enrolled into the study, with 10% (n ¼
252) pre-enrolled into the study before becoming pregnant. Of these,
32 women withdrew from the study. We excluded 227 women for
ineligibility due to being .12 weeks’ gestation at the time of enroll-
ment, being lost to follow-up (unreachable by study staff for .7
weeks) or relocating outside the study areas. We further excluded
69 women with second or third study pregnancies, 8 with invalid
key data elements for pregnancy dating and 23 with multiple gestation
pregnancies. These exclusions resulted in a total of 2407 women in
the final analysis (Chan et al., 2009).
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The majority of the study participants (82.5%) were recruited
from the Raleigh or Memphis study areas. Mean age at enrollment
was 27.8 years (SD ¼ 5.5) and mean gestational age at enrollment
was 54.8 days (SD ¼ 14.0). Although non-Hispanic White women
made up over 50% of the cohort, a substantial proportion (31.7%)
was non-Hispanic Blacks. Very few women reported being smokers
or consumers of alcohol during pregnancy (Chan et al., 2009).
Approximately 45% were considered overweight or obese prior to
pregnancy based on the World Health Organization cutpoints
(World Health Organization). Almost half were nulliparious and 21%
reported having had a prior pregnancy loss (Table I). There were
258 (10.7%) SABs in this study population, and percent SAB did not
vary by study site.
As stated in an earlier report (Chan et al., 2009), 89% of the
women in this cohort experienced some form of NVP, and more
than half (53.0%) report experiencing symptoms of nausea with vomit-
ing episodes (Table I). Further, onset for NVP was most likely to begin
in early pregnancy, with 99% of initial nausea symptoms and 95.3% of
initial vomiting episodes taking place in the first trimester (Chan et al.,
2009). When vomiting was at its worst, 51% reported vomiting once a
day and 13% reported having more than three vomiting episodes daily.
On average, women with both nausea and vomiting reported having
vomiting episodes 3.3 days each week when symptoms were con-
sidered ‘the worst’ by the women. The median onset time for
nausea symptoms was 5.7 weeks and that for vomiting episodes
was 7.0 weeks from LMP (data not shown) (Chan et al., 2009). The
overall mean symptom duration was eight gestational weeks.
Week-specific conditional probability of SAB by NVP status and
symptom duration is shown in Fig. 1. There was a 3- to 10-fold increase
in risk of first trimester pregnancy loss for women without NVP symp-
toms, compared with women who experienced some NVP symptoms;
however, the risk of SAB for women without NVP symptoms reverts to
the baseline risk after the first trimester. Risk of SAB by week in the first
trimester did not differ greatly for women with a shorter duration (NVP
,half pregnancy at given week j) than those with a longer duration; no
difference in risk was seen between groups beyond the first trimester
based on duration of NVP symptoms.
Overall, women with no symptoms had three times the odds of
having an SAB [OR ¼ 3.2, 95% CI: (2.4, 4.3)] compared with
women with any form of NVP symptoms. Table II shows the results
........................................................................................
Table I Sociodemographic characteristics, selected
maternal behavior, and reproductive histories of








,25 years old 725 30.1
25–29 years old 746 31.0
30–34 years old 654 27.2
≥35 years old 282 11.7
Race/ethnicity
Non-Hispanic White 1346 56.0




,12 years 712 29.5
≥12 to ,16 years 516 21.5





≤$40 000/year 1003 43.4
$40 001–$80 000/year 765 33.2
.$80 000/year 540 23.4
Smoking
None 2276 94.5
,10 cigarettes/day 86 3.6





Underweight (,18.5) 87 3.7
Normal weight (18.5–24.9) 1191 50.8
Overweight (25.0–29.9) 564 24.1
Obese (≥30.0) 502 21.4
Age at menarche
≤11 years old 531 22.2
12–13 years old 1258 52.7










No prior loss 720 29.9
≥1 pregnancy with no loss 1178 48.9
≥1 pregnancy with ≥1 loss 509 21.2
NVPb symptom severity
No symptom 279 11.6
Nausea symptoms only 852 35.4
Nausea and vomiting 1274 53.0
aBMI, body mass index, based on World Health Organization classifications.
bNVP, nausea and vomiting during pregnancy.
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of modeling the week-specific odds of a woman having an early preg-
nancy loss for the different characteristics of NVP symptoms, stratified
by maternal age. Adjustment for the potentially confounding factors
did not materially alter the OR estimates. Compared with women
with nausea and vomiting, the OR for no NVP symptom and SAB
increased with increasing maternal age, from an OR of 4.0 [95% CI:
(2.1, 7.6)] for women ,25 years old to an OR of 11.7 [95% CI:
(4.5, 26.7)] for women 35 years and older (likelihood ratio test P ,
0.0001). An unvarying and more moderate pattern of association
was found across maternal age groups for having nausea symptoms
only, compared with nausea and vomiting. Maternal age also modified
the association between duration and SAB. Compared with no symp-
toms, longer duration (NVP ≥half pregnancy) was found to have a
much reduced odds for SAB among the oldest maternal age group
[OR ¼ 0.2, 95% CI: (0.1, 0.8) for ≥35 years old]. However, this
pattern of association was not observed in the younger age groups.
Fixed effects by study site did not alter the magnitude of association.
Discussion
In a prospective cohort study, we examined the associations between
the subgroups of NVP and SAB in a population of women recruited
early in their pregnancy or women who were planning a pregnancy.
The prevalence of NVP (35.4% for nausea symptoms only, 53.0% for
both symptoms) was within the range for nausea symptoms only (20–
50%) and for both symptoms (48–80%) reported by previous cohort
studies (Kallen et al., 2003; Lagiou et al., 2003; Weigel et al., 2006);
the prevalences for nausea only and both nausea symptoms and
Figure 1 Week-specific conditional probability of pregnancy loss by NVP status and symptom duration, Right from the Start (2000–2004).
....................................... ...........................................................................................................
.................... ....................... ....................... ................. ...
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Table II Unadjusted and adjusted OR on the association between NVPa symptom severity and duration and risk of
pregnancy loss and adjusted ORs stratified by maternal age: Right from the Start (2000–2004), n 5 2407.
NVP characteristics Main effects model Models with an interaction term (maternal age)














No symptoms 5.7 (4.0, 8.0) 5.1 (3.6, 7.3) 4.0 (2.1, 7.6) 3.9 (1.9, 8.0) 6.5 (3.2, 13.2) 11.7 (4.5, 26.7)
Nausea only 2.4 (1.8, 3.3) 2.5 (1.8, 3.4) 2.0 (1.5, 2.8) 2.0 (1.4, 2.9) 2.5 (1.8, 3.6) 3.4 (2.2, 5.4)
Symptom duratione
NVP ,half pregnancy 0.5 (0.4, 0.6) 0.5 (0.4, 0.6) 1.0 (0.2, 1.7) 1.1 (0.6, 2.2) 0.7 (0.4, 1.4) 0.4 (0.2, 0.9)
NVP ≥half pregnancy 0.2 (0.2, 0.3) 0.3 (0.2, 0.4) 1.0 (0.3, 3.4) 1.3 (0.4, 4.6) 0.5 (0.1, 2.1) 0.2 (0.1, 0.8)
aNVP, nausea and vomiting during pregnancy.
bOR, odds ratio.
cCI, confidence interval.
dCompared with symptoms of both nausea and vomiting; models stratified by maternal age and adjusted for maternal race and ethnicity, education, marital status, alcohol use, age at
menarche, parity and pregnancy loss history.
eCompared with no symptoms; models stratified by maternal age and adjusted for maternal race and ethnicity, education, marital status, alcohol use, age at menarche, parity and
pregnancy loss history.
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vomiting episodes are higher than those reported in other cohort studies
in which recruitment took place exclusively in prenatal clinics (Gadsby
et al., 1993; Weigel et al., 2006). Symptom duration was found to be
within the range for mean duration (8–12 gestational weeks) as seen
in the literature (Zhou et al., 1999; Kallen et al., 2003), but a sizable pro-
portion of our cohort reported their symptoms lasting for 6 weeks or
less. This may be linked to our study design that collected symptom
data early in pregnancy, increasing the completeness of reporting and
thus may have included more short-duration symptom reports. We
observed an increase in risk for SAB that was limited to mid-first trime-
ster among women without NVP, and no observable difference in risk
was seen after the first trimester in this group compared with women
with NVP (regardless of duration). The gestational weeks during
which heightened weekly probability of SAB was seen, corresponded
to a critical window in embryonic and early fetal development for
viable pregnancies.
In addition to confirming earlier findings that absence of NVP symp-
toms is associated with pregnancy loss, we also were able to provide
evidence that longer duration of symptoms reduced risk of pregnancy
loss. The mechanisms by which NVP predicts favorable pregnancy
outcome are not known; nevertheless, several different mechanisms
have been postulated to explain the reported feto-protective effect
of NVP. These include the role of NVP in reducing fetal exposure
to potential teratogens present in the maternal diet (Weigel and
Weigel, 1989a), improving the quality of maternal diets to favor the
consumption of certain nutrients, increasing energy expenditure that
alters hormonal balance in favor of maternal and fetal tissue growth
(Weigel and Weigel, 1989a; Coad et al., 2002), along with other
dietary pathways. Alternatively, one theory suggests NVP simply is a
reflection of maternal sensitivity to hormones (e.g. hCG) that them-
selves are related to pregnancy outcome (Stein and Susser, 1991;
Forbes, 2002).
Our findings also provided insights into the contribution of maternal
age in the etiology of SAB. The effects of symptom severity and duration
were found to be different across maternal age groups. The risk for SAB
related to no NVP symptoms increased with increasing maternal age.
Shorter symptom duration was associated with decreasing risk for
SAB as maternal age increases; the same pattern was seen in longer
symptom duration but the decrease in SAB in older women was
more marked compared with younger women. Some of the ORs
were imprecise within maternal age categories, and caution in interpret-
ation is warranted. It is known that the rate of pregnancy loss begins to
increase for women between ages 30 and 35, resulting from chromoso-
mally aberrant or chromosomally normal losses (Kline et al., 1989), with
each having a different underlying biological process. While losses from
chromosomal abnormalities are related to the quality of the ovum and
the viability of the conceptus, chromosomally normal losses are likely
related to anatomical or physiological changes that occur with age.
Our finding suggested that, among women of ages 30 and over, the pres-
ence of NVP may reflect increased oocyte and embryo quality relative to
women without NVP. The extent to which this explains the effect of
NVP on age-specific outcome is not known. The use of assisted repro-
duction techniques registries suggested strongly that the effect of
increasing age on early pregnancy loss is related to decreases in
oocyte and embryo quality (Schieve et al., 2003).
The strengths of this study include our ability to enroll from the
community (37%) and prospectively collect data from newly pregnant
women early in pregnancy, thus allowing for a more complete assess-
ment and minimizing misclassification from recall bias. Moreover,
studies of early pregnancy loss are subject to left truncation because
a proportion of the source population is excluded due to pregnancy
losses prior to recruitment (Hertz-Picciotto et al., 1989; Howards
et al., 2007); our analytical methods account for left truncation in mini-
mizing biased effect estimates due to participation differential by
outcome.
Our analysis builds upon past research on the association between
NVP symptoms and SAB; nevertheless, limitations still exist in our
study regarding the information collected on NVP symptoms. First,
misclassification of exposure reporting and of the timing of NVP
from self-reported data could have occurred; however, because
NVP assessment took place prior to recognition of 71% of pregnancy
losses (the remaining 29% interviewed after loss), the potential for
recall error would be limited. Second, we imputed symptom ending
dates for 18% of women with any NVP symptoms who reported
that their symptoms had not subsided at the time of the interview;
even if symptom duration for them was calculated from an actual
ending date, the effect estimates would have been impacted minimally
because all women were censored by week 20, an end-point in the
gestational period that was reflective of a time when most symptoms
are expected to subside (Lacroix et al., 2000). Third, we did not
collect information daily on NVP symptoms; hence, we made assump-
tions that a woman’s symptom was always “nausea only” or always
“nausea and vomiting”. The variability in patterns of the NVP cycle
and the direct influences from such characteristics on SAB cannot
be directly addressed. Lastly, although we utilized community recruit-
ment and targeted recruitment at women who were early in their ges-
tation period or those who were not yet pregnant, we still could have
missed capturing women with subclinical pregnancy losses and a frac-
tion of clinically recognized losses because of missed enrollment,
potentially producing more imprecise estimates and underestimating
the magnitude of the associations.
In conclusion, we found, as have others, the presence of NVP
decreases the risk of SAB, with this decrease higher in women 30
years and older. We also found that the effect of symptom duration
is greatest among that group. With a more complete assessment of
the timing and occurrence of NVP and the use of biochemical
assays, we may achieve a better understanding of the biological and
physiological mechanisms of NVP and in turn, elucidate the possible
interplay between this common pregnancy phenomenon and modifi-
able risk factors (e.g. smoking, alcohol, environmental toxicants) as
well as non-modifiable risk factors (e.g. age, chromosomal karyotype)
associated with pregnancy loss.
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